Australian Specialized REITs Stock News

If you are wondering whether Pantoro Gold is still good value after a strong run, this article walks through the key numbers so you can judge the price tag for yourself. The share price last closed at A$3.79, with returns of 53.8% over 1 year and a very large gain over 3 years, even though the stock has seen a 33.6% decline over 7 days, a 15.0% decline over 30 days and a 26.6% decline year to date. Recent coverage of Pantoro Gold has focused on how gold producers are being reassessed by...

Why Flight Centre Travel Group is back on investors’ radar Flight Centre Travel Group (ASX:FLT) has just wrapped up a half year marked by higher sales, steady net income, a new A$0.12 dividend, and completion of a sizeable A$126 million share buyback. See our latest analysis for Flight Centre Travel Group. Despite the dividend announcement and completion of the A$126 million buyback, the share price return has been weak recently, with a 30 day share price return decline of 13.18% and a 1 year...

Vault Minerals (ASX:VAU) recently released half year results that combined higher sales, a swing to net loss, an affirmed ordinary dividend, and updated gold production figures, giving investors several moving parts to assess. See our latest analysis for Vault Minerals. At a share price of A$5.11, Vault Minerals has seen short term pressure, including a 7 day share price return of an 11.13% decline. Its 1 year total shareholder return of 94.42% and 3 year total shareholder return of a little...

Waypoint REIT has reported its full-year 2025 results, with sales of A$162.6 million versus A$163.9 million a year earlier, and net income rising to A$200.1 million from A$131.5 million. Despite slightly lower sales, the sharp increase in basic earnings per share from continuing operations to A$0.3019 from A$0.1957 highlights improved profitability and cost efficiency across the portfolio. We’ll now look at how this stronger earnings performance, especially the jump in net income, may...

Aeris Resources Limited recently reported half-year results to 31 December 2025, with sales of A$306.3 million and net income of A$47.91 million, and appointed experienced governance professional Ms Sally McDow as joint Company Secretary alongside CFO Ms Dane Van Heerden, effective 25 February 2026. The combination of higher sales and earnings per share from continuing operations, together with strengthened company secretarial oversight, highlights Aeris Resources’ focus on both operational...

Earnings jump puts Black Cat Syndicate (ASX:BC8) in focus Black Cat Syndicate (ASX:BC8) has drawn fresh attention after reporting half year sales of A$169.09 million and net income of A$34.58 million for the period ended December 31, 2025. This result contrasts with the same period a year earlier, when the company reported A$1.14 million in sales and a net loss of A$9.71 million, and shifts earnings per share into positive territory. See our latest analysis for Black Cat Syndicate. At a...

MFF Capital Investments has reported weekly net tangible assets per share of A$4.720 pre-tax and A$4.056 post-tax as at 6 March 2026, confirmed a 10 cent fully franked interim dividend, and scheduled an online-only shareholder webinar for 18 March 2026 with senior management presenting and taking questions. Director Chris Mackay’s recent on-market share purchases, combined with the upcoming webinar and maintained dividend, highlight stronger alignment between management and shareholders and...

Whitehaven Coal (ASX:WHC) has drawn fresh attention after reporting results for the six months to 31 December 2025 and pairing them with an interim dividend, along with a matching share buyback announcement. See our latest analysis for Whitehaven Coal. The latest interim dividend and buyback news comes after a strong run in the share price over the past year, with a 1 year total shareholder return of 52.14% and a 5 year total shareholder return of around 7x. Shorter term momentum has picked...

Zimplats Holdings Limited reported half-year results for the period ended December 31, 2025, with sales rising to US$641.75 million and net income to US$143.72 million, both sharply higher than a year earlier. The jump in basic earnings per share from US$0.04 to US$1.34 highlights a significant turnaround in profitability over the prior comparable period. We’ll now explore how this sharp rebound in profitability shapes Zimplats Holdings’ investment narrative and what it might mean for...

Why Helia Group is back on investor radars Helia Group (ASX:HLI) has drawn fresh attention after releasing its full year 2025 earnings, setting insurance revenue guidance for 2026, and declaring both an ordinary dividend and a sizeable special dividend. See our latest analysis for Helia Group. Despite a 2.68% one day share price decline and recent volatility around the A$5.81 level, Helia’s 39.48% one year total shareholder return and very large five year total shareholder return suggest...

Santos Limited (ASX:STO) has reportedly been weighing a demerger of its lower-performing Western Australia, Cooper Basin, Narrabri and Dorado assets as part of an Australian business strategic review that sources say could involve either an in‑specie distribution or an outright sale to a buyer such as Beach Energy. This potential separation of non-core assets, and the associated remediation liabilities, could reshape Santos into a more focused LNG and Alaska portfolio that may be more...

Dicker Data (ASX:DDR) has drawn fresh attention after releasing its full year 2025 results, reporting higher sales, revenue and net income, and declaring a fully franked final quarterly dividend of A$0.115 per share. See our latest analysis for Dicker Data. Despite the full year 2025 results and higher fully franked dividend drawing focus, Dicker Data’s 1 day share price return of 3.6% comes after weaker recent momentum. The 90 day share price return of 13.82% and 1 year total shareholder...

Neuren Pharmaceuticals Limited has reported its full-year 2025 results, with revenue of A$84.84 million and net income of A$30.44 million, both materially lower than the prior year’s levels. The sharp reduction in basic earnings per share from continuing operations, from A$1.1117 to A$0.2373, highlights how recent financial performance contrasts with earlier analyst expectations for the business. We’ll now examine how this sharp drop in annual revenue and earnings shapes Neuren...

Greatland Resources (ASX:GGP) has appointed Mr. Ben Secrett as Company Secretary and governance lead. The appointment marks a change in leadership for corporate governance and regulatory oversight at the company. This governance update has not yet been widely covered in the market news flow. Greatland Resources (ASX:GGP) operates in the resources sector, where investor attention often focuses on project development, funding access and regulatory compliance. In this context, the Company...

NEXTDC Limited recently reported half-year results for the period to 31 December 2025, recording a net loss of A$39.35 million, while also confirming fiscal 2026 net revenue guidance in the range of A$390 million to A$400 million. The narrowing loss compared with the previous year, together with management’s decision to reaffirm revenue expectations, highlights a focus on scaling the business while working to contain bottom-line pressures. Next, we’ll examine how the reaffirmed full-year...

Earnings rebound and dividend announcement put Ramsay Health Care in focus Ramsay Health Care (ASX:RHC) has drawn fresh attention after reporting half year earnings to 31 December 2025 that moved from a loss to a profit, alongside a declared interim dividend. See our latest analysis for Ramsay Health Care. The earnings rebound and interim dividend have landed against a mixed price backdrop, with a 16.39% 1 month share price return and 17.27% 3 month share price return, but a 34.91% 3 year...

Why Catalyst Metals’ latest half year earnings matter Catalyst Metals (ASX:CYL) has put fresh numbers on the table, reporting half year sales of A$267.85 million and net income of A$59.7 million, tied to higher basic and diluted earnings per share. See our latest analysis for Catalyst Metals. The latest half year earnings have landed after a sharp reset in sentiment, with the 1 day share price return of 11.34% decline and 7 day return of 19.36% decline contrasting with a 90 day share price...

Woolworths Group has already reported half-year results to January 4, 2026, with net income of A$374 million and basic earnings per share of A$0.306 from continuing operations, while also declaring an increased fully franked interim dividend of A$0.45 per share, which went ex-dividend on March 4, 2026. The combination of a sharp earnings decline alongside a higher cash payout raises questions about how Woolworths is balancing profit pressures with shareholder returns. We’ll now examine how...

PYC Therapeutics Limited recently completed a follow-on equity offering raising about A$584.14 million, issuing multiple tranches of ordinary shares at A$1.50 each, including a rights issue and subsequent direct listing on the ASX. The capital raise, combined with the recent half-year results showing lower revenue and a reduced net loss, materially reshapes PYC’s funding profile and ownership structure as it progresses its therapeutic programs. We’ll now examine how this large equity...

Tabcorp Holdings reported past half-year results to 31 December 2025, with revenue rising slightly to A$1,344.9 million while net profit eased to A$21.7 million, and basic earnings per share from continuing operations slipped to A$0.009. Despite the softer earnings, the company lifted its interim unfranked dividend by 50% to A$0.015 per share, signalling a more generous capital return stance that may reshape how investors view its payout policy and cash flow priorities. We’ll now examine how...

Why Clinuvel’s latest half year result has caught investor attention Clinuvel Pharmaceuticals (ASX:CUV) has drawn fresh interest after reporting half year earnings to 31 December 2025, with revenue of A$40.56 million and net income of A$10.44 million, both below the prior period. See our latest analysis for Clinuvel Pharmaceuticals. At a share price of A$10.16, Clinuvel’s recent half year result lands against a backdrop of weaker momentum, with a 30 day share price return of 8.14% and a 90...

Why MAAS Group Holdings Just Drew Fresh Attention MAAS Group Holdings (ASX:MGH) has come into focus after reporting half year results to 31 December 2025 and confirming a new distribution, giving investors fresh numbers to assess both earnings and income potential. See our latest analysis for MAAS Group Holdings. The latest half year earnings and new A$0.035 per share distribution have arrived alongside a 30 day share price return of 18.10% and a 1 year total shareholder return of 34.18%. The...

Metallurgical breakthrough sharpens focus on Maverick Springs Sun Silver (ASX:SS1) has drawn fresh attention after reporting metallurgical test work at its Maverick Springs project, with 78% silver recovery and 77% gold recovery supporting the potential for a low capital heap leach operation. For investors, the news gives clearer technical context to a stock that remains an early stage explorer and it sets out a pathway toward further studies, including a planned scoping level assessment...

American Tungsten & Antimony recently entered a trading halt and applied to quote 25 million new ordinary shares on the ASX under an employee incentive scheme, alongside updates on its Dutch Mountain, Tennessee Mountain and Nightingale tungsten projects in the United States. The combination of a trading halt with a sizeable employee-focused share issuance highlights how the company is reshaping its capital structure and internal incentives around its tungsten development pipeline. Next, we...